283 related articles for article (PubMed ID: 22960106)
21. The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy.
Kariya S; Mauricio R; Dai Y; Monani UR
Neurosci Lett; 2009 Jan; 449(3):246-51. PubMed ID: 19010394
[TBL] [Abstract][Full Text] [Related]
22. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
[TBL] [Abstract][Full Text] [Related]
23. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
Feng Z; Lam S; Tenn ES; Ghosh AS; Cantor S; Zhang W; Yen PF; Chen KS; Burden S; Paushkin S; Ayalon G; Ko CP
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360794
[TBL] [Abstract][Full Text] [Related]
24. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.
Kariya S; Park GH; Maeno-Hikichi Y; Leykekhman O; Lutz C; Arkovitz MS; Landmesser LT; Monani UR
Hum Mol Genet; 2008 Aug; 17(16):2552-69. PubMed ID: 18492800
[TBL] [Abstract][Full Text] [Related]
25. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
[TBL] [Abstract][Full Text] [Related]
26. Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.
Dachs E; Hereu M; Piedrafita L; Casanovas A; Calderó J; Esquerda JE
J Neuropathol Exp Neurol; 2011 Jun; 70(6):444-61. PubMed ID: 21572339
[TBL] [Abstract][Full Text] [Related]
27. SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy.
Hunter G; Aghamaleky Sarvestany A; Roche SL; Symes RC; Gillingwater TH
Hum Mol Genet; 2014 May; 23(9):2235-50. PubMed ID: 24301677
[TBL] [Abstract][Full Text] [Related]
28. Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.
Udina E; Putman CT; Harris LR; Tyreman N; Cook VE; Gordon T
J Physiol; 2017 Mar; 595(5):1815-1829. PubMed ID: 27891608
[TBL] [Abstract][Full Text] [Related]
29. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
[TBL] [Abstract][Full Text] [Related]
30. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
Kim JK; Caine C; Awano T; Herbst R; Monani UR
Hum Mol Genet; 2017 Jul; 26(13):2377-2385. PubMed ID: 28379354
[TBL] [Abstract][Full Text] [Related]
31. Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy.
Poort JE; Rheuben MB; Breedlove SM; Jordan CL
Hum Mol Genet; 2016 Sep; 25(17):3768-3783. PubMed ID: 27493028
[TBL] [Abstract][Full Text] [Related]
32. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
[TBL] [Abstract][Full Text] [Related]
33. Hyperexcitability precedes motoneuron loss in the
Quinlan KA; Reedich EJ; Arnold WD; Puritz AC; Cavarsan CF; Heckman CJ; DiDonato CJ
J Neurophysiol; 2019 Oct; 122(4):1297-1311. PubMed ID: 31365319
[TBL] [Abstract][Full Text] [Related]
34. Embryonic motor axon development in the severe SMA mouse.
McGovern VL; Gavrilina TO; Beattie CE; Burghes AH
Hum Mol Genet; 2008 Sep; 17(18):2900-9. PubMed ID: 18603534
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing.
Voigt T; Meyer K; Baum O; Schümperli D
Neuromuscul Disord; 2010 Nov; 20(11):744-52. PubMed ID: 20832308
[TBL] [Abstract][Full Text] [Related]
36. The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.
Hosseinibarkooie S; Peters M; Torres-Benito L; Rastetter RH; Hupperich K; Hoffmann A; Mendoza-Ferreira N; Kaczmarek A; Janzen E; Milbradt J; Lamkemeyer T; Rigo F; Bennett CF; Guschlbauer C; Büschges A; Hammerschmidt M; Riessland M; Kye MJ; Clemen CS; Wirth B
Am J Hum Genet; 2016 Sep; 99(3):647-665. PubMed ID: 27499521
[TBL] [Abstract][Full Text] [Related]
37. Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy.
Hann SH; Kim SY; Kim YL; Jo YW; Kang JS; Park H; Choi SY; Kong YY
Elife; 2024 Feb; 12():. PubMed ID: 38318851
[TBL] [Abstract][Full Text] [Related]
38. Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.
Yoshida M; Kitaoka S; Egawa N; Yamane M; Ikeda R; Tsukita K; Amano N; Watanabe A; Morimoto M; Takahashi J; Hosoi H; Nakahata T; Inoue H; Saito MK
Stem Cell Reports; 2015 Apr; 4(4):561-8. PubMed ID: 25801509
[TBL] [Abstract][Full Text] [Related]
39. Defining the therapeutic window in a severe animal model of spinal muscular atrophy.
Robbins KL; Glascock JJ; Osman EY; Miller MR; Lorson CL
Hum Mol Genet; 2014 Sep; 23(17):4559-68. PubMed ID: 24722206
[TBL] [Abstract][Full Text] [Related]
40. Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.
Moloney EB; Hobo B; De Winter F; Verhaagen J
PLoS One; 2017; 12(1):e0170314. PubMed ID: 28103314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
